MasTec, Inc. (NYSE:MTZ) issued an update on its second quarter earnings guidance on Monday morning. The company provided EPS guidance of $0.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.53, StockRatingsNetwork.com reports. The company issued revenue guidance of $1.1 billion, compared to the consensus revenue estimate of $1.16 billion.
MasTec, Inc. (NYSE:MTZ) stock opened today at $31.49 and is currently trading at $31.81. The stock showed a negative weekly performance of -6.20%.
Puma Biotechnology, Inc. (NYSE:PBYI) announced the presentation of positive results from an ongoing Phase II clinical trial of Puma’s investigational drug PB272 (neratinib) for the treatment of HER2 positive metastatic breast cancer that has metastasized to the brain. The data was presented today in a poster presentation at the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting in Chicago, Illinois. Puma Biotechnology Inc. (NYSE:PBYI) stock opened at $64.85, in current trading session and currently is at $59.16, by losing -22.60%. The 52 week range of $33.58 – $143.65. Company’s market capitalization is 1.78 billion.
National-Oilwell Varco, Inc.(NYSE:NOV) -9.5% premarket after completing the spinoff to its stockholders of its distribution business as an independent public company, NOW Inc.Merrill Miller Jr. steps down as NOV’s Executive Chairman to hold the same position with NOW; Clay Williams is NOV’s Chairman.NOW common stock begins trading today on the NYSE under the ticker symbol DNOW. National-Oilwell Varco, Inc. (NYSE:NOV) stock is currently trading at $74.19. The EPS of the stock is 5.64. Company’s market capitalization is 31.83 billion.
On May 29, 2014, the United States Natural Gas Fund, LP (NYSEARCA:UNG) issued its monthly account statement for the month ended April 30, 2014, which is presented in the form of a Statement of Income (Loss) and a Statement of Changes in Net Asset Value, as required pursuant to Rule 4.22 under the Commodity Exchange Act. A copy of the monthly account statement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and also can be found on the Registrant’s website at www.unitedstatesnaturalgasfund.com. United States Natural Gas Fund, LP (NYSEARCA:UNG) stock opened the session at $25.07, and now is at $25.32. The 52 week range of the United States Natural Gas Fund, LP (NYSEARCA:UNG) stock remained $16.59 – $27.89 and the day range was $25.04 – $25.34.
Obesity is a medical problem that now has drug treatment options. Prior to FDA approval, investor interest in Arena Pharmaceuticals (NASDAQ:ARNA) soared. Since the FDA approved Belviq, Arena began to market and sell the drug. Sales are steady but not as strong as initially thought. This creates an opportunity in pharmaceutical stocks for investors with a long term time horizon. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock opened today at $6.14 and is currently trading at $6.06. The stock showed a negative weekly performance of -1.60%.